Concepedia
Statistics
Publications
8
Citations
887
H-Index
Active since
1993
Affiliations
Institut Gustave Roussy(Current)
Centre Léon Bérard
D Abigerges is an author at Institut Gustave Roussy specializing in medicine, pharmacology, and clinical pharmacology.
Publications per year
1993–2018
Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.
D Abigerges, G G Chabot, Jean‐Pierre Armand et al. · Journal of Clinical Oncology · 1995 · 299 citations
Medicine, Oncology, Pharmacology +17
Irinotecan (CPT-11) High-Dose Escalation Using Intensive High-Dose Loperamide to Control Diarrhea
D Abigerges, P. Armand, G G Chabot et al. · JNCI Journal of the National Cancer Institute · 1994 · 245 citations
Medicine, Oncology, Pharmacology +15
Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials
G G Chabot, D Abigerges, G. Catimel et al. · Annals of Oncology · 1995 · 173 citations
Medicine, Pharmacokinetics, Pharmacology +11
High dose-intensity of irinotecan administered every 3 weeks in advanced cancer patients: a feasibility study.
Yacine Merrouche, Jean Marc Extra, D Abigerges et al. · Journal of Clinical Oncology · 1997 · 51 citations
Pharmacy, Oncology, Pharmacology +17
Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study
Pieter W. Kamphuisen, A.Y.Y. Lee, Guy Meyer et al. · Journal of Thrombosis and Haemostasis · 2018 · 40 citations · Full text
Medicine, Hematology, Oncology +17
1–5 of 8